Literature DB >> 2405808

Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients.

M Davidson, P D Harvey, R L Bergman, P Powchik, R Kaminsky, M F Losonczy, K L Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2405808     DOI： 10.1001/archpsyc.1990.01810140090014

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  7 in total

1.  Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors.

Authors:  Lin Pei; Frank J S Lee; Anna Moszczynska; Brian Vukusic; Fang Liu
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

Review 2.  [Treatment of cognitive deficits in schizophrenia. Part 2: Pharmacological strategies].

Authors:  D Roesch-Ely; U Pfueller; C Mundt; U Müller; M Weisbrod
Journal:  Nervenarzt       Date:  2010-05       Impact factor: 1.214

Review 3.  Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.

Authors:  José A Apud; Daniel R Weinberger
Journal:  NeuroRx       Date:  2006-01

4.  Comparison of the enantiomers of (+/-)-doxanthrine, a high efficacy full dopamine D(1) receptor agonist, and a reversal of enantioselectivity at D(1) versus alpha(2C) adrenergic receptors.

Authors:  Julie A Przybyla; Juan P Cueva; Benjamin R Chemel; K Joseph Hsu; David J Riese; John D McCorvy; Julia A Chester; David E Nichols; Val J Watts
Journal:  Eur Neuropsychopharmacol       Date:  2008-11-22       Impact factor: 4.600

5.  Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.

Authors:  Anissa Abi-Dargham; Jonathan A Javitch; Mark Slifstein; Alan Anticevic; Monica E Calkins; Youngsun T Cho; Clara Fonteneau; Roberto Gil; Ragy Girgis; Raquel E Gur; Ruben C Gur; Jack Grinband; Joshua Kantrowitz; Christian Kohler; John Krystal; John Murray; Mohini Ranganathan; Nicole Santamauro; Jared Van Snellenberg; Zailyn Tamayo; Daniel Wolf; David Gray; Jeffrey Lieberman
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

6.  Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients.

Authors:  Y T Kwak; M S Koo; C H Choi; I Sunwoo
Journal:  BMC Med Genet       Date:  2001-03-05       Impact factor: 2.103

Review 7.  The role of dopamine receptors in lymphocytes and their changes in schizophrenia.

Authors:  M A Penedo; T Rivera-Baltanás; D Pérez-Rodríguez; J Allen; A Borrajo; D Alonso-Crespo; C Fernández-Pereira; M Nieto-Araujo; S Ramos-García; C Barreiro-Villar; H J Caruncho; J M Olivares; R C Agís-Balboa
Journal:  Brain Behav Immun Health       Date:  2021-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.